These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32837338)

  • 61. Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.
    Kleinert RDV; Montoya-Diaz E; Khera T; Welsch K; Tegtmeyer B; Hoehl S; Ciesek S; Brown RJP
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31627415
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of immunity against Yellow Fever virus infections in northeastern Nigeria using three serological assays.
    Baba MM; Yahaya KM; Ezra EM; Adamu M; Kulloma BM; Ikusemoran M; Momoh JP; Oderinde BS
    J Med Virol; 2021 Aug; 93(8):4856-4864. PubMed ID: 33783842
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Yellow Fever Virus Maintained by
    de Oliveira CH; Andrade MS; Campos FS; da C Cardoso J; Gonçalves-Dos-Santos ME; Oliveira RS; Aquino-Teixeira SM; Campos AA; Almeida MA; Simonini-Teixeira D; da P Sevá A; Temponi AOD; Magalhães FM; da Silva Menezes AS; Lopes BT; Almeida HP; Pedroso AL; Gonçalves GP; Chaves DCC; de Menezes GG; Bernal-Valle S; Müller NF; Janssen L; Dos Santos E; Mares-Guia MA; Albuquerque GR; Romano AP; Franco AC; Ribeiro BM; Roehe PM; Lourenço-de-Oliveira R; de Abreu FVS
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992466
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Community-based sero-prevalence of chikungunya and yellow fever in the South Omo Valley of Southern Ethiopia.
    Endale A; Michlmayr D; Abegaz WE; Asebe G; Larrick JW; Medhin G; Legesse M
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008549. PubMed ID: 32881913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Yellow Fever Emergence: Role of Heterologous Flavivirus Immunity in Preventing Urban Transmission.
    Shinde DP; Plante JA; Scharton D; Mitchell B; Walker J; Azar SR; Campos RK; Sacchetto L; Drumond BP; Vasilakis N; Plante KS; Weaver SC
    bioRxiv; 2024 Mar; ():. PubMed ID: 38463973
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid molecular assays for the detection of yellow fever virus in low-resource settings.
    Escadafal C; Faye O; Sall AA; Faye O; Weidmann M; Strohmeier O; von Stetten F; Drexler J; Eberhard M; Niedrig M; Patel P
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2730. PubMed ID: 24603874
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study.
    Doshi RH; Mukadi PK; Casey RM; Kizito GM; Gao H; Nguete U B; Laven J; Sabi L; Kaba DK; Muyembe-Tamfum JJ; Hyde TB; Ahuka-Mundeke S; Staples JE
    Lancet Infect Dis; 2024 Jun; 24(6):611-618. PubMed ID: 38335976
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Yellow fever and orthotopic liver transplantation: new insights from the autopsy room for an old but re-emerging disease.
    Duarte-Neto AN; Cunha MDP; Marcilio I; Song ATW; de Martino RB; Ho YL; Pour SZ; Dolhnikoff M; Saldiva PHN; Duarte MIS; Takakura CF; Lima FR; Tanigawa RY; Iglezias SD; Kanamura CT; Dos Santos ABG; Perondi B; Zanotto PMA; D'Albuquerque LAC; Alves VAF
    Histopathology; 2019 Nov; 75(5):638-648. PubMed ID: 31087672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk of yellow fever virus importation into the United States from Brazil, outbreak years 2016-2017 and 2017-2018.
    Dorigatti I; Morrison S; Donnelly CA; Garske T; Bowden S; Grills A
    Sci Rep; 2019 Dec; 9(1):20420. PubMed ID: 31892703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Detection and Molecular Characterization of Yellow Fever Virus, 2017, Brazil.
    Figueiredo PO; Silva ATS; Oliveira JS; Marinho PE; Rocha FT; Domingos GP; Poblete PCP; Oliveira LBS; Duarte DC; Bonjardim CA; Abrahão JS; Kroon EG; Drumond BP; Oliveira DB; Trindade GS
    Ecohealth; 2018 Dec; 15(4):864-870. PubMed ID: 30117000
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.
    Garske T; Van Kerkhove MD; Yactayo S; Ronveaux O; Lewis RF; Staples JE; Perea W; Ferguson NM;
    PLoS Med; 2014 May; 11(5):e1001638. PubMed ID: 24800812
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo.
    Nzolo D; Engo Biongo A; Kuemmerle A; Lusakibanza M; Lula Y; Nsengi N; Nsibu Ndosimao C; Tona Lutete G; Van Geertruyden JP
    Vaccine; 2018 Oct; 36(41):6170-6182. PubMed ID: 30190119
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study.
    Kraemer MUG; Faria NR; Reiner RC; Golding N; Nikolay B; Stasse S; Johansson MA; Salje H; Faye O; Wint GRW; Niedrig M; Shearer FM; Hill SC; Thompson RN; Bisanzio D; Taveira N; Nax HH; Pradelski BSR; Nsoesie EO; Murphy NR; Bogoch II; Khan K; Brownstein JS; Tatem AJ; de Oliveira T; Smith DL; Sall AA; Pybus OG; Hay SI; Cauchemez S
    Lancet Infect Dis; 2017 Mar; 17(3):330-338. PubMed ID: 28017559
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination of surveillance tools reveals that Yellow Fever virus can remain in the same Atlantic Forest area at least for three transmission seasons.
    Abreu FVS; Delatorre E; Dos Santos AAC; Ferreira-de-Brito A; de Castro MG; Ribeiro IP; Furtado ND; Vargas WP; Ribeiro MS; Meneguete P; Bonaldo MC; Bello G; Lourenço-de-Oliveira R
    Mem Inst Oswaldo Cruz; 2019; 114():e190076. PubMed ID: 31038550
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence for multiple sylvatic transmission cycles during the 2016-2017 yellow fever virus outbreak, Brazil.
    Moreira-Soto A; Torres MC; Lima de Mendonça MC; Mares-Guia MA; Dos Santos Rodrigues CD; Fabri AA; Dos Santos CC; Machado Araújo ES; Fischer C; Ribeiro Nogueira RM; Drosten C; Sequeira PC; Drexler JF; Bispo de Filippis AM
    Clin Microbiol Infect; 2018 Sep; 24(9):1019.e1-1019.e4. PubMed ID: 29427798
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunisation.
    Possas C; Lourenço-de-Oliveira R; Tauil PL; Pinheiro FP; Pissinatti A; Cunha RVD; Freire M; Martins RM; Homma A
    Mem Inst Oswaldo Cruz; 2018 Sep; 113(10):e180278. PubMed ID: 30427974
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mapping and Validation of Peptides Differentially Recognized by Antibodies from the Serum of
    Oliveira ES; Tavares NC; Colombarolli SG; Batista ICA; Nascimento CS; Felgner PL; de Assis RR; Calzavara-Silva CE
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016268
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The interplay between environmental factors, vector competence and vaccine immunodynamics as possible explanation of the 2019 yellow fever re-emergence in Nigeria.
    Abdullahi IN; Anka AU; Emeribe AU; Umar K; Adekola HA; Uzairue L; Ghmaba PE; Okwume CC
    New Microbes New Infect; 2021 May; 41():100858. PubMed ID: 33912348
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A community-level investigation following a yellow fever virus outbreak in South Omo Zone, South-West Ethiopia.
    Mulchandani R; Massebo F; Bocho F; Jeffries CL; Walker T; Messenger LA
    PeerJ; 2019; 7():e6466. PubMed ID: 30809451
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Absence of Yellow Fever in Asia: History, Hypotheses, Vector Dispersal, Possibility of YF in Asia, and Other Enigmas.
    Kuno G
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33255615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.